Screen-film mammography bests computed radiography

September 15, 2013
Screen-film mammography bests computed radiography
Computed radiography systems are 21 percent less effective at detecting breast cancers than screen-film mammography, according to a study published in the September issue of Radiology.

(HealthDay)—Computed radiography (CR) systems are 21 percent less effective at detecting breast cancers than screen-film mammography (SFM), according to a study published in the September issue of Radiology.

Anna M. Chiarelli, Ph.D., from Cancer Care Ontario in Toronto, and colleagues followed concurrent cohorts of women (aged 50 to 74 years) screened with digital direct radiography (DR) (220,520 women), CR (64,210), or SFM (403,688; the reference cohort) between 2008 and 2009.

The researchers found that the cancer detection rate was similar for DR (4.9 per 1,000) and SFM (4.8 per 1,000); however, the rate was significantly lower for CR (3.4 per 1,000; odds ratio, 0.79). Compared to recall rates for SFM (7.4 percent), recall rates for DR were higher (7.7 percent) and recall rates for CR were lower (6.6 percent). For CR, the was non-significantly lower (5.2 percent) than for SFM (6.6 percent).

"Screening programs should monitor the performance of CR separately and may consider informing women of the potentially lower rates," the authors write.

Explore further: Digital mammography cancer detection rates may vary significantly

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Digital mammography cancer detection rates may vary significantly

May 14, 2013
Digital direct radiography (DR) is significantly more effective than computed radiography (CR) at detecting breast cancer, according to a new study published online in the journal Radiology.

Digital mammography improves population-based breast cancer screening

October 2, 2012
New research from the Netherlands shows that the switch from screen film mammography (SFM) to digital mammography (DM) in large, population-based breast cancer screening programs improves the detection of life-threatening ...

Tomosynthesis reduces breast cancer screening recall rate

July 30, 2013
Digital tomosynthesis is an effective tool for reducing the recall rate in breast cancer screening, according to a new study published online in the journal Radiology.

Specificity up with stereoscopic mammography for CA detection

January 18, 2013
(HealthDay)—Three-dimensional stereoscopic digital mammography (DM) significantly improves the specificity and accuracy of breast cancer detection, with a lower patient recall rate and a sensitivity comparable to that of ...

Digital breast tomosynthesis cuts recall rates by 40 percent

May 3, 2012
Adding digital breast tomosynthesis to 2D mammography screening results in a 40% reduction in patient recall rates compared to routine screening mammography alone, a new study shows.

Tomosynthesis ups accuracy of digital mammography

January 4, 2013
(HealthDay)—Using a combination of tomosynthesis, which produces a three-dimensional reconstruction of the breast, with digital mammography increases radiologists' diagnostic accuracy and significantly lowers the number ...

Recommended for you

Lung cancer triggers pulmonary hypertension

November 17, 2017
Shortness of breath and respiratory distress often increase the suffering of advanced-stage lung cancer patients. These symptoms can be triggered by pulmonary hypertension, as scientists at the Max Planck Institute for Heart ...

Researchers discover an Achilles heel in a lethal leukemia

November 16, 2017
Researchers have discovered how a linkage between two proteins in acute myeloid leukemia enables cancer cells to resist chemotherapy and showed that disrupting the linkage could render the cells vulnerable to treatment. St. ...

Computer program finds new uses for old drugs

November 16, 2017
Researchers at the Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine have developed a computer program to find new indications for old drugs. The computer program, called DrugPredict, ...

Pharmacoscopy improves therapy for relapsed blood cancer in a first clinical trial

November 16, 2017
Researchers at CeMM and the Medical University of Vienna presented a preliminary report in The Lancet Hematology on the clinical impact of an integrated ex vivo approach called pharmacoscopy. The procedures measure single-cell ...

Wider sampling of tumor tissues may guide drug choice, improve outcomes

November 15, 2017
A new study focused on describing genetic variations within a primary tumor, differences between the primary and a metastatic branch of that tumor, and additional diversity found in tumor DNA in the blood stream could help ...

A new strategy for prevention of liver cancer development

November 14, 2017
Primary liver cancer is now the second leading cause of cancer-related death worldwide, and its incidences and mortality are increasing rapidly in the United Stated. In late stages of the malignancy, there are no effective ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.